Cargando…
Synthesis and Bioactivity Evaluation of a Novel 1,2,4-Oxadiazole Derivative in vitro and in 3×Tg Mice
AIM: Alzheimer’s disease (AD) is the most common neurodegenerative disease whose patients suffered from cognitive impairments. In our study, a novel 1,2,4-Oxadiazole derivative wyc-7-20 was synthesized, which showed low cytotoxicity and potent neuroprotective effect at the cellular level. Improved c...
Autores principales: | Luo, Zhuohui, Wang, Yongcheng, Pang, Shuo, Gao, Shan, Liu, Ning, Gao, Xiang, Zhang, Li, Qi, Xiaolong, Yang, Yajun, Zhang, Lianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521684/ https://www.ncbi.nlm.nih.gov/pubmed/36187086 http://dx.doi.org/10.2147/DDDT.S372750 |
Ejemplares similares
-
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles †
por: Baykov, Sergey V., et al.
Publicado: (2023) -
Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
por: Pang, Shuo, et al.
Publicado: (2023) -
Reactions of 1,2,4‐Oxadiazole[4,5‐a]piridinium Salts with Alcohols: the Synthesis of Alkoxybutadienyl 1,2,4‐Oxadiazoles
por: Moiola, Mattia, et al.
Publicado: (2020) -
Design, synthesis, and biological activity of novel 1,2,4-oxadiazole derivatives
por: Zhu, Lingzhi, et al.
Publicado: (2020) -
Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review
por: Wang, Jing-Jing, et al.
Publicado: (2022)